CClinicalTrials.gg
CompletedNCT00569959Updated Nov 26, 2015

Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients

An interventional study of fasting 12+ hours and Non-fasting in Diabetes Mellitus, Normal Glucose Metabolism and Hyperlipidemia, sponsored by HealthPartners Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-11-26.

Sponsored by HealthPartners Institute · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

This study will examine whether fasting and non-fasting lipid measures can provide similar clinical information in order to guide lipid management by primary physicians. It will compare fasting vs. non-fasting lipid measurements in patients with and without diabetes.

02

Conditions studied

  • Diabetes Mellitus
  • Normal Glucose Metabolism
  • Hyperlipidemia

Keywords

  • fasting lipid measures
  • non-fasting lipid measures
  • clinical decision-making
  • LDL-Cholesterol
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 50 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

HealthPartners Institute is the lead sponsor of 164 studies on the registry; 20 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 16 (94%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Park Nicollet Health Services patients due for routine lipid measures

Exclusion criteria

Exclusion Criteria:

  • Unwilling or unable to provide consent
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Other
    Fasting

    Other: fasting 12+ hours

  • Other
    Non-fasting

    Other: Non-fasting

Interventions

  • Otherfasting 12+ hours

    fasting 12+ hours

  • OtherNon-fasting

    Non-fasting

06

What researchers measure

Primary outcomes

  1. LDL-Cholesterol

    Time frame: Fasting 12+ hours vs. Non-fasting

Secondary outcomes

  1. Other lipid parameters

    Time frame: Fasting 12+ hours vs. non-fasting

07

Study locations

1 site
  • Park Nicollet Internal and Family Medicine Clinics
    Minneapolis, Minnesota 55416, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00569959
Lead sponsor
HealthPartners Institute
First posted
Dec 10, 2007
Start date
Nov 2006
Completion
Jun 2007
Last update
Nov 26, 2015

Study contacts

William Richards, MD
principal investigator · Park Nicollet Health Services

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion